Journal profile · Gastroenterology & Hepatology
Hepatobiliary & Pancreatic Diseases International
ISSN 1499-3872 · eISSN 2352-9377 · Elsevier (Singapore) Pte Ltd · PEOPLES R CHINA · Bimonthly · Founded 2002
Hepatobiliary & Pancreatic Diseases International: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.79; subscription journal; median 201 days to acceptance (99 articles, last 24 months); community-reported acceptance: about 50%; 96 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Hepatobiliary & Pancreatic Diseases International is published by Elsevier (Singapore) Pte Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Organ Transplantation Techniques and Outcomes, Hepatocellular Carcinoma Treatment and Prognosis and Pancreatic and Hepatic Oncology Research, together about 33.6% of its articles. Its main subfields are Surgery and Hepatology. (generated from OpenAlex topic counts and CAS ranking data)
Hepatobiliary & Pancreatic Diseases International (HBPD INT) (ISSN 1499-3872 / CN 33-1391/R), owned by the First Affiliated Hospital, Zhejiang University School of Medicine in China, publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases.Papers cover the medical, surgical, radiological, pathological, biochemical, physiological and histological aspects of the subject areas under the headings Liver, Biliary, Pancreas, Transplantation, Research, Special Reports, Editorials, Review Articles, Brief Reports, Clinical Summary, New Techniques, and Clinical Images. The journal also deals with the basic sciences and experimental work. All submitted papers are reviewed by at least two referees expert in the field of the submitted paper. Manuscripts, letters, and other communications should be submitted via https://mc03.manuscriptcentral.com/hbpdint.If you require further information or help, please contact: Hepatobiliary & Pancreatic Diseases International, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, China. Tel: +86-571- 87236559, +86-571-87236600; Fax: +86-571-87236559; Email: hbpdint@126.com, hbpdje@zju.edu.cn.
From the journal's Aims & Scope
Research area (LetPub): Gastroenterology & Hepatology
Editor-in-chief Shu-Sen ZhengPublisher website
Editorial board by country: 1 in mainland China (about 11%); most named Hong Kong, China 6, Mainland China 1, United Kingdom 1, Israel 1 (9 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Organ Transplantation Techniques and OutcomesMedicine12.1%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine11.6%
- Pancreatic and Hepatic Oncology ResearchMedicine9.8%
- Gallbladder and Bile Duct DisordersMedicine9.4%
- Cholangiocarcinoma and Gallbladder Cancer StudiesMedicine8.7%
- Liver Disease and TransplantationMedicine8.3%
- Pancreatitis Pathology and TreatmentMedicine6.4%
- Liver Disease Diagnosis and TreatmentMedicine6.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Gastroenterology & Hepatology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.79LetPub ·
- Impact factor (publisher)
- 3.9Publisher website ·
- CiteScore 2026-06
- 7.2LetPub ·
- CiteScore (publisher)
- 7.2Publisher website ·
- SJR 2026-06
- 1.02LetPub ·
- SNIP 2026-06
- 1.15LetPub ·
- h-index
- 40LetPub ·
- h-index
- 57OpenAlex ·
- i10-index
- 738OpenAlex ·
- 2-year mean citedness
- 1.49OpenAlex ·
- Self-citation rate
- 5.1%LetPub ·
- Share of gold OA articles
- 4.3%LetPub ·
Volume
- Articles per year
- 63LetPub ·
Articles by year OpenAlex count · 1,847 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 74 | 3 | 16 |
| 2025 | 96 | 2 | 136 |
| 2024 | 82 | 7 | 223 |
| 2023 | 119 | 19 | 770 |
| 2022 | 141 | 10 | 1,373 |
| 2021 | 127 | 7 | 1,219 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
201 daysMedian, submission to acceptance · P25–P75 152 days – 260 days
- Acceptance to online
- median 5 days (99 articles)
- Submission to online
- median 213 days
- Sample
- 99 articles with submission and acceptance dates (227 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Acceptance to publication
- 8 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 300 words
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted3, with length limits
- correspondenceLetters to the editor on matters of recently published articles in the journal are especially welcome, which should not exceed 400 words. Letters of general int…Length not stated
- letterLetters to the editor on matters of recently published articles in the journal are especially welcome, which should not exceed 400 words. Letters of general int…main text ≤ 1,500 words
- letters to the editorLetters to the editor on matters of recently published articles in the journal are especially welcome, which should not exceed 400 words. Letters of general int…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, …
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Peer review Peer review
This journal operates a single anonymized review process. All contributions are typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themse…
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier (Singapore) Pte Ltd
- Country or region
- PEOPLES R CHINA
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2002
- ISSN
- 1499-3872
- Electronic ISSN
- 2352-9377
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Hepatobiliary & Pancreatic Diseases International
What CAS zone is Hepatobiliary & Pancreatic Diseases International in?
In the 2025 upgraded edition of the CAS Journal Ranking, Hepatobiliary & Pancreatic Diseases International is in Zone 3 of Medicine, and in Zone 4 of the minor category Gastroenterology & Hepatology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Hepatobiliary & Pancreatic Diseases International?
The latest impact factor listed by LetPub is 3.79; CiteScore 7.2, h-index 57.
How long does peer review take at Hepatobiliary & Pancreatic Diseases International?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 201 days (interquartile range 152–260 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Hepatobiliary & Pancreatic Diseases International?
According to the journal's author guidelines: Abstract: ≤ 300 words; Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Hepatobiliary & Pancreatic Diseases International based?
Of the 9 board members whose country the journal's board page names, 1 (about 11%) are in mainland China; the countries named most often are Hong Kong, China (6), Mainland China (1) and United Kingdom (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Hepatobiliary & Pancreatic Diseases International?
According to LetPub and DOAJ records, Hepatobiliary & Pancreatic Diseases International is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Hepatobiliary & Pancreatic Diseases International open access, and what is the APC?
Hepatobiliary & Pancreatic Diseases International is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .